STOCKHOLM, Aug. 17, 2021 /PRNewswire/ -- SyntheticMR
have entered a general software license agreement for distribution
with Siemens Healthineers. The agreement enables Siemens
Healthineers to market, sell and distribute SyntheticMR's product
package SyMRI NEURO to their customers in various markets globally
such as in the US, in Europe
(CE-markets), Japan, India, Brazil, Saudi
Arabia, and ANZ.
SyntheticMR and Siemens Healthineers signed a cooperation
agreement in 2016, since 2018, SyMRI NEURO has been available
for purchase on the Siemens Healthineers Digital Marketplace. The
product can be seamlessly integrated in the clinical workflow. In
addition to this, SyMRI NEURO can now be purchased together with
MAGNETOM MRI scanners directly from Siemens Healthineers.
"Through our partnership with SyntheticMR, we are further
transforming syngo.via and Syngo Carbon into an independent
advanced visualization platform while extending our reading &
reporting solution", says Oliver
Klinkow, Vice President of Marketing and Sales at Syngo. "We
are excited to see the SyMRI Neuro functionality available as part
of our solution."
"This license agreement is an important step towards a deeper
collaboration with Siemens Healthineers on a global level," says
Ulrik Harrysson, CEO, SyntheticMR. "We see a high level of interest
in our medical imaging solutions to further enhance MRI workflows
and provide decision support, and we are pleased to work together
with Siemens Healthineers to bring this to the global market. The
agreement represents a significant addition to our sales resources
and enables us to further support our customers and healthcare
providers worldwide."
About Siemens Healthineers
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is
shaping the future of healthcare. As a leading medical technology
company headquartered in Erlangen, Germany, Siemens Healthineers enables
healthcare providers worldwide through its regional companies to
increase value by empowering them on their journey towards
expanding precision medicine, transforming care delivery, improving
the patient experience, and digitalizing healthcare. Siemens
Healthineers is continuously developing its product and service
portfolio, with AI-supported applications and digital offerings
that play an increasingly important role in the next generation of
medical technology. These new applications will enhance the
company's foundation in in-vitro diagnostics, image-guided therapy,
in-vivo diagnostics, and innovative cancer care. Siemens
Healthineers also provides a range of services and solutions to
enhance healthcare providers' ability to provide high-quality,
efficient care to patients. In fiscal 2020, which ended on
September 30, 2020, Siemens
Healthineers generated revenue of €14.5 billion and adjusted EBIT
of €2.2 billion. Following the acquisition of Varian Medical
Systems, Inc. the company has approximately 66,000 employees
worldwide. Further information is available
at www.siemens-healthineers.com.
About SyntheticMR
SyntheticMR AB develops and markets innovative software solutions
for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed
SyMRI®, delivering multiple, adjustable contrast images and
quantitative data from a single fast scan. The SyMRI product is
available in different packages. SyMRI NEURO delivers multiple
contrast images, tissue segmentations and quantitative data on the
brain. SyMRI MSK provides multiple contrast images and quantitative
data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k)
cleared, SyMRI MSK is CE-marked and FDA 510(k) pending. SyMRI is a
registered trademark in Europe and
the USA. SyntheticMR is listed on
the Spotlight Stock Market Exchange in Stockholm, Sweden. For additional information,
please visit www.syntheticmr.com.
CONTACT:
For additional information, please contact Ulrik
Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87
or ulrik.harrysson@syntheticmr.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/syntheticmr-ab/r/syntheticmr-and-siemens-healthineers-collaboration-extended---symri-neuro-now-directly-available-thr,c3397416
The following files are available for download:
|
https://mb.cision.com/Main/11663/3397416/1454963.pdf
|
Release
|
View original
content:https://www.prnewswire.com/news-releases/syntheticmr-and-siemens-healthineers-collaboration-extended---symri-neuro-now-directly-available-through-siemens-healthineers-301357004.html
SOURCE SyntheticMR AB